Anzeige
Mehr »
Mittwoch, 25.03.2026 - Börsentäglich über 12.000 News
+2.000% bisher - kommt jetzt der nächste Antimon-Trade? A2 Gold zündet die nächste Stufe!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Pharmaceutical Technology

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
02.02.CIRM unveils RAPID funding programme for rare diseases
30.01.FDA's new scheme to boost US manufacturing commences despite uncertainty
30.01.Sanofi touts strong new launch sales amid looming Dupixent patent expiry
30.01.AstraZeneca signs $18.5bn weight loss drug deal with CSPC
30.01.IQVIA and Boehringer Ingelheim collaborate on therapeutic data transformation
30.01.Repertoire and Lilly join hands on autoimmune disease therapies
29.01.AstraZeneca pours $15bn into Chinese R&D and manufacturing operations
29.01.Roche's 2025 profit blunted by weakened US dollar
29.01.Sensorion announces $71.9m reserved offering to expand gene therapy pipeline
29.01.FDA grants breakthrough status to Biogen's litifilimab for CLE
28.01.Eli Lilly outlays $1.12bn for hearing loss gene therapy partnership
28.01.CMS selects next batch of 15 high-cost medicines for third negotiation cycle
28.01.FDA accepts Otsuka's centanafadine application for ADHD treatment
28.01.Insilico and Qilu Pharmaceutical sign deal for cardiometabolic therapies
27.01.UK and certain European countries lose WHO's measles-free status
27.01.Mirum acquires Bluejay Therapeutics to expand rare liver disease pipeline
27.01.FDA to review Eisai's Leqembi Iqlik sBLA for Alzheimer's
26.01.Internet of Medical Things beats AI as top ranked growth driver among life science CEOs
26.01.UK biotechs suffered restricted financing in 2025
26.01.MSD ends takeover talks with Revolution Medicines
26.01.NICE greenlights Pfizer's Talzenna for NHS use
23.01.Corxel raises $287m as obesity continues to spark investor interest
23.01.Daiichi Sankyo and AstraZeneca's Enhertu gains NMPA approval for HER2 GEJ
22.01.BMS bets on Janux's novel solid tumour therapy through $850m deal
22.01.US set to officially exit WHO in culmination of Trump's domestic push